July 19, 2019 Texas HIV Medication Advisory Committee
»
1. Call to Order and Welcome - Philip Keiser, M.D., Committee Chair
1. Call to Order and Welcome - Philip Keiser, M.D., Committee Chair
»
2. Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
2. Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
»
4. LIDS Update/Legislative Update – Imelda Garcia, Associate Commissioner, DSHS
4. LIDS Update/Legislative Update – Imelda Garcia, Associate Commissioner, DSHS
»
5. Budget Update – Felipe Rocha, MSSW Director TB/HIV/STD Section
5. Budget Update – Felipe Rocha, MSSW Director TB/HIV/STD Section
»
6. THMP Update – Rachel Sanor, Manager
6. THMP Update – Rachel Sanor, Manager
»
7. Presentation on Dovato – Viiv Healthcare, Medical Science Liaison
7. Presentation on Dovato – Viiv Healthcare, Medical Science Liaison
»
3. Review and Approval of April 5, 2019, Meeting Minutes - Sallie Allen, Advisory Committee Coordination Office, HHSC
3. Review and Approval of April 5, 2019, Meeting Minutes - Sallie Allen, Advisory Committee Coordination Office, HHSC
»
Items 8 (Part 1 of 2), 9, & 10 » - 8. Sub-Committee Reports (Governance/Data – Phillip Keiser, Eligibility – Frank Rosas, and Formulary – Natalie Vanek) 9. MAC to vote for addition of the following medications a. Dovato b. Hepatitis B medications c. Hepatitis C medications 10. MAC to vote for removal of the following medications a. Delavirdine b. Indinavir
Items 8 (Part 1 of 2), 9, & 10 »
8. Sub-Committee Reports (Governance/Data – Phillip Keiser, Eligibility – Frank Rosas, and Formulary – Natalie Vanek) 9. MAC to vote for addition of the following medications
a. Dovato
b. Hepatitis B medications
c. Hepatitis C medications
10. MAC to vote for removal of the following medications
a. Delavirdine
b. Indinavir
»
11. MAC to vote on officer elections process
11. MAC to vote on officer elections process
»
Item 8 (Part 2 of 2) » - 8. Sub-Committee Reports (Governance/Data – Phillip Keiser, Eligibility – Frank Rosas, and Formulary – Natalie Vanek)
Item 8 (Part 2 of 2) »
8. Sub-Committee Reports (Governance/Data – Phillip Keiser, Eligibility – Frank Rosas, and Formulary – Natalie Vanek) »
Additional Item
Additional Item
»
Items 13 & 14 » - 13. Action items and agenda topics for next scheduled meeting October 18, 2019 - Philip Keiser, M.D., Chair 14. Adjourn - Philip Keiser, M.D., Committee Chair
Items 13 & 14 »
13. Action items and agenda topics for next scheduled meeting October 18, 2019 - Philip Keiser, M.D., Chair 14. Adjourn - Philip Keiser, M.D., Committee Chair
